Introduction

Medial-compartment osteoarthritis (OA) – the wear and tear that affects the inner part of the knee – is a common condition that can seriously impact mobility and everyday activities. Many people find that walking or standing causes pain, which affects their quality of life. Arthrosamid is a newer injectable treatment that’s gaining attention for specifically targeting this inner-knee discomfort. This focused approach is important because the medial compartment often bears extra weight due to a varus (bow-legged) load, speeding up cartilage wear and worsening pain. In this article, we explore why targeting this area makes a difference and who might benefit most from Arthrosamid.

Understanding Medial-Compartment Knee OA: Challenges and Everyday Impact

Medial-compartment knee OA is different from other forms because the inner knee joint tends to carry a larger share of the body’s weight. This varus alignment increases stress on the cartilage, causing it to wear away faster and leading to pain that’s often localised inside the knee. As a result, people may struggle with walking longer distances or standing for any length of time. The physical toll is paired with emotional challenges — frustration and worry are common as mobility becomes limited. These complex issues underline the importance of specialised care that addresses the unique difficulties of medial-knee OA.

Arthrosamid: How It Works and Why It Helps the Inner Knee

Arthrosamid is an injectable hydrogel designed to ease pressure inside the knee by cushioning and supporting the joint where the cartilage has worn thin. It helps reduce friction and absorbs shock, particularly in the medial compartment, which suffers the most from varus loading and cartilage loss. While results can vary from patient to patient, research shows that Arthrosamid can help improve mobility and make standing or walking more comfortable. A recent study found that “PAAG provided improvement in knee OA symptoms over 24 months, in older, non-diabetic patients with lower KL grades” (Gao et al., 2025a). It’s important to remember that these are possible benefits rather than guaranteed outcomes.

Expert Care at MSK Doctors: Professor Paul Lee and Team

Professor Paul Lee is a leading figure in knee and cartilage treatment, serving as a Cartilage Expert and Regional Surgical Ambassador, and affiliated with the Royal College of Surgeons of Edinburgh. At MSK Doctors, he works alongside a skilled multidisciplinary team that puts patients first, offering expert advice and personalised care for knee OA. Their collective experience helps patients feel supported and informed, especially when considering treatments like Arthrosamid. While they did not develop this treatment, their guidance is invaluable for navigating available options safely and effectively.

Setting Realistic Expectations and Making Informed Decisions

If you’re considering Arthrosamid for medial-compartment OA, expect your initial consultation to involve a thorough assessment of your symptoms and knee health. The injection is minimally invasive, but recovery and the level of symptom relief will vary between patients. It is vital to maintain realistic expectations: many people do report better walking ability and less pain when standing, yet outcomes depend on many factors. A recent study emphasises that “the absence of a control group and limited outcome measures should be considered. Further studies are warranted to validate efficacy, refine patient selection, and evaluate long-term impact” (Gao et al., 2025a). Working closely with expert clinicians like those at MSK Doctors helps ensure that treatment decisions are based on sound evidence and personalised care.

Conclusion

For those dealing with medial-compartment knee osteoarthritis, targeted treatments such as Arthrosamid offer a promising way to reduce inner-knee discomfort and improve mobility. The best results come with specialist guidance within a professional medical setting that values individualised, evidence-based care. If persistent inner-knee pain is affecting your daily life, expert advice is a crucial step towards finding the right treatment and regaining your quality of life.

References

• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., & Lee, P. Y. (2025). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.02.648
• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma, 103136. https://doi.org/10.1016/j.jcot.2025.103136